MODIFICATION ASAHI NEW PAN-SERIES HEMOFILTERS— 510(k) K855251

Name: FDA 510(k) clearance K855251
Creator: U.S. Food and Drug Administration
Published: 1986-02-04

Substantially Equivalent

Advocacy International, Ltd.

FDA 510(k) clearance K855251 for MODIFICATION ASAHI NEW PAN-SERIES HEMOFILTERS, Substantially Equivalent on 1986-02-04. Applicant: Advocacy International, Ltd.. Device class: 2.

Clearance details

Applicant: Advocacy International, Ltd.
Product code: Code KDI
Device class: Class 2
Regulation: 21 CFR 876.5860
Advisory panel: Gastroenterology, Urology
Date received: 1985-12-30
Decision date: 1986-02-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Washington, DC, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KDI

view all

K261267 — Careflux H60; Careflux H70; Careflux V5002026-07-24
K252377 — NxStage System One with NxView2026-05-15
K260533 — ELISIO-H2026-03-19
K252459 — multiFlux 130 (F00013123); multiFlux 160 (F00013124)2026-02-10
K253412 — Tablo Hemodialysis System (PN-0008000, PN-0006000U)2026-01-26

More clearances from Advocacy International, Ltd.

view all

K874027 — LIPASE UV [TOYO]1988-05-27
K873792 — SEPACELL R-500 AND SEPACELL R-500A1988-01-19
K855212 — ASAHI AM SERIES DIALYZERS1986-01-21
K854259 — SEPACELL R-500 & SEPACELL R-500A1986-01-08
K842103 — TOYO JOZO URIC ACID TEST1984-08-12

Adverse events under product code KDI

product code KDI

Death: 352
Injury: 1,474
Malfunction: 12,534
Other: 4
Total: 14,364

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.